Skip to main content
Figure 3 | BMC Pulmonary Medicine

Figure 3

From: The surfactant protein C mutation A116D alters cellular processing, stress tolerance, surfactant lipid composition, and immune cell activation

Figure 3

Viability of MLE12 cells expressing SP-C WT or SP-C A116D before and after treatment with drugs used in therapy. MLE-12 cells stably expressing SP-CWT or SP-CA116D were incubated for 24 hours with 10 Ī¼M each of cyclophosphamide (+Cyc), azathioprine (+Aza), methylprednisolone (+Met), or hydroxychloroquine (+Hyd). LDH release, a sign of decreased cell fitness, of treated vs. untreated (-) cells is expressed as % of total LDH. Only significant p-values are depicted.

Back to article page